Therapie des akuten Nierenversagens[1]

Literatur

• 1 Abramson S, Singh A K. Continous renal replacement therapy compared with intermittend hemodialysis in intensive care: which is better?.  Curr Opin Nephrol Hypertens. 1999;  8 537-541
• 2 Allgren R L, Marbury C, Rahman S N. et al . Anaritide in acute tubular necrosis.  N Engl J Med. 1997;  336 828-834
• 3 Barrett B J, Carlisle E J. Metaanalysis of the relative nephrotoxicity of high and low-osmolality iodinated contrast media.  Radiology. 1993;  188 171-178
• 4 Berns A S. Nephrotoxicity of contrast media.  Kidney Int. 1989;  36 730-740
• 5 Burke T J, Arnold P E, Gordon J A, Bulger R E, Dobyan D C, Schrier R W. Protective effect of intrarenal calcium membrane blockers before or after renal ischemia.  J Clin Invest. 1984;  74 1830-1841
• 6 Chertow G M, Lazarus J M, Paganini E P, Allgren R L, Lafayette R A, Sayegh M H. The Auricullin Anaritide Acute Renal Failure Study Group . Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis.  J Am Soc Nephrol. 1998;  9 692-698
• 7 Erley C M, Duda S H, Rehfuss D. et al . Prevention of radiocontrast-media induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline.  Nephrol Dial Transplant. 1999;  14 1146-1149
• 8 Franklin S C, Moulton M, Sicard G A, Hammermann M R, Miller S B. Insulin-like growth factor I preserves renal function postoperatively.  Am J Physiol. 1997;  272 F257-259
• 9 Hatala R, Dinh T, Cook D J. Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis.  Ann Intern med. 1996;  124 717-725
• 10 Hirschberg R, Kopple J, Lipsett P. et al . Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure.  Kidney Int. 1999;  55 2423-2432
• 11 Ichai C, Passeron C, Carles M, Bouregba M, Grimaud D. Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable, critically ill patients: a single-blind, prospective, controlled study.  Crit Care Med. 2000;  28 1329-1335
• 12 Jörres A, Gahl G M, Dobis C. et al . Haemodialysis-membrane biocompatibility and mortality of patients wih dialysis-dependent acute renal failure: a prospective randomised multicentre trial.  Lancet. 1999;  354 1337-1341
• 13 Kellum J A. Use of diuretics in the acute care setting.  Kidney Int. 1998;  53 S67-S70 (Suppl 66))
• 14 Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery.  J Am Soc Nephrol. 2000;  11 97-104
• 15 Lehnert T, Keller E, Gondolf K, Schäffner T, Pavenstädt H, Schollmeyer P. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.  Nephrol Dial Transplant. 1998;  13 358-362
• 16 Levy E M, Viscoli C M, Horwitz R I. The effect of acute renal failure on mortality: A cohort analysis.  JAMA. 1996;  275 1489-1494
• 17 Lewis J, Salem M M, Chertow G M, Weisberg L S, Mc Grew  F, Marbury T C, Allgren R L. Anaritide acute renal failure study group . Atrial natriuretic factor in oliguric acute renal failure.  Am J Kidney Dis. 2000;  36 767-774
• 18 Marik P E, Iglesias J. NORASEPT II Study Investigators . Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria.  Am J Med. 1999;  107 387-390
• 19 Neumayer H H, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomized clinical trial.  Nephrol Dial Transplant. 1989;  4 1030-1036
• 20 Noiri E, Peresleni T, Miller F, Goligorsky M S. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia.  J Clin Invest. 1996;  97 2377-2383
• 21 Nolan C R, Anderson R J. Hospital aquired acute renal failure.  J Am Soc Nephrol. 1998;  9 710-718
• 22 Rabb H, O¿Meara Y, Maderna P, Coleman P, Brady H R. Leucocytes, cell adhesion molecules and ischemic acute renal failure.  Kidney Int. 1997;  51 1463-1468
• 23 Rahman S N, Kim G E, Mathew A S. et al . Effects of atrial natriuretic peptide in clinical acute renal failure.  Kidney Int. 1994;  45 1731-1738
• 24 Rodicio J L, Ruilope L M. Assessing renal effects and renal protection.  J Hypertens Suppl. 1995;  13 S19-S25
• 25 Ronco C, Bellomo R, Homl P. et al . Effects of different doses in continous veno-venous haemofilration on outcomes of acute renal failure: a prospective randomised trial.  Lancet. 2000;  356 26-30
• 26 Rudnick M R, Berns J S, Cohen R M, Goldfarb S. Contrast media-associated nephrotoxicity.  Curr Opin Nephrol Hypertens. 1996;  5 127-123
• 27 Ruschitzka F, Shaw S, Gygi D, Noll G, Barton M, Lüscher T F. Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.  J Am Soc Nephrol. 1999;  10 953-962
• 28 Schiffl H, Lang S M, König A, Strasser T, Haider M C, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study.  Lancet. 1994;  344 570-572
• 29 Shilliday I R, Quinn K J, Allison M E. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-contolled, randomized study.  Nephrol Dial Transplant. 1997;  12 2592-2596
• 30 Singer I, Epstein M. Potential of dopamine A-1 agonists in the management of acute renal failure.  Am J Kidney Dis. 1998;  31 743-755
• 31 Solomon R, Werner C, Mann D, D¿Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal fuction induced by radiocontrast agents.  N Engl J Med. 1994;  331 1416-1420
• 32 Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.  N Engl J Med. 2000;  343 180-184
• 33 Zager R A. Rhabdomyolysis and myohemoglobinuric acute renal failure.  Kidney Int. 1996;  45 314-326

1 Der Beitrag »Diagnostik des akuten Nierenversagens« ist im vorhergehenden Heft (Nr. 1/2) erschienen.

Korrespondenz